Processing and presentation of murine cytomegalovirus pORFm164-derived peptide in fibroblasts in the face of all viral immunosubversive early gene functions

Journal of Virology

Volumn 76, Issue 12, 2002, Pages 6044-6053

  Holtappels, Rafaela ^a   Grzimek, Natascha K A ^a   Simon, Christian O ^a   Thomas, Doris ^a   Dreis, Doris ^a   Reddehase, Matthias J ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALANYLGLYCYLPROLYLPROLYLARGINYLTYROSYLSERYLARGINYLISOLEUCINE; ANTIGEN; GENE PRODUCT; POLYPEPTIDE; TYROSYLPROLYLHISTIDYLPHENYLALANYLMETHIONYLPROLYLTHREONYLASPARAGINYLLEUCINE; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ANTIGEN PRESENTATION; ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOTOXIC T LYMPHOCYTE; FIBROBLAST; GENE EXPRESSION; GENE FUNCTION; IMMUNE RESPONSE; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; PRIORITY JOURNAL; VIRUS REPLICATION;

ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, VIRAL; CELLS, CULTURED; FEMALE; FIBROBLASTS; GENES, IMMEDIATE-EARLY; IMMEDIATE-EARLY PROTEINS; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; MUROMEGALOVIRUS; OPEN READING FRAMES; PEPTIDE FRAGMENTS; T-LYMPHOCYTES, CYTOTOXIC; VIRAL PROTEINS;

EID: 0036100579     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.76.12.6044-6053.2002     Document Type: Article

References (70)

1. Viral mechanisms of immune evasion
2. Control of cytomegalovirus in bone marrow transplantation chimeras lacking the prevailing antigen-presenting molecule in recipient tissues rests primarily on recipient-derived CD8 T cells
3. Infection of dendritic cells by murine cytomegalovirus induces functional paralysis
4. + T cells is regulated by virus-induced, soluble-mediator-dependent maturation of dendritic cells
5. + T cell help
6. A subset of viral transcripts packaged within human cytomegalovirus particles
7. Cytomegalovirus
8. Analysis of the protein-coding content of the sequence of human cytomegalovirus strain AD169
9. Cytomegalovirus prevents antigen presentation by blocking the transport of peptide-loaded major histocompatibility complex class I molecules into the medial-Golgi compartment
10. Presentation of CMV immediate-early antigen to cytolytic T lymphocytes is selectively prevented by viral genes expressed in the early phase
11. Molecular basis for cytolytic T-lymphocyte recognition of the murine cytomegalovirus immediate-early protein pp89
12. Molecular cloning and physical mapping of murine cytomegalovirus DNA
13. Identification of naturally processed viral nonapeptides allows their quantification in infected cells and suggests an allele-specific T cell epitope forecast
14. Cellular peptide composition governed by major histocompatibility complex class I molecules
15. + T lymphocytes in healthy seropositive donors
16. Products of US22 genes M140 and M141 confer efficient replication of murine cytomegalovirus in macrophages and spleen
17. Replication of murine cytomegalovirus in differentiated macrophages as a determinant of viral pathogenesis
18. Immune evasion by cytomegalovirus - Survival strategies of a highly adapted opportunist
19. Restoration of cytomegalovirus antigen presentation by gamma interferon combats viral escape
20. Macrophages escape inhibition of major histocompatibility complex class I-dependent antigen presentation by cytomegalovirus
21. Early gene m18, a novel player in the immune response to murine cytomegalovirus
22. Control of murine cytomegalovirus in the lungs: Relative but not absolute immunodominance of the immediate-early 1 nonapeptide during the antiviral cytolytic T-lymphocyte response in pulmonary infiltrates
23. Experimental preemptive immunotherapy of murine cytomegalovirus disease with CD8 T-cell lines specific for ppM83 and pM84, the two homologs of human cytomegalovirus tegument protein ppUL83 (pp65)
24. The putative natural killer decoy early gene m04 (gp34) of murine cytomegalovirus encodes an antigenic peptide recognized by protective antiviral CD8 T cells
25. d haplotype
26. d-restricted antigenic peptide encoded by murine cytomegalovirus early gene M84
27. Regulation of herpesvirus macromolecular synthesis. I. Cascade regulation of the synthesis of three groups of viral proteins
28. Regulation of herpesvirus macromolecular synthesis: Sequential transition of polypeptide synthesis requires functional viral polypeptides
29. Cytomegalovirus infectivity: Analysis of the phenomenon of centrifugal enhancement of infectivity
30. The multiple immune-evasion genes of murine cytomegalovirus are not redundant: m4 and m152 inhibit antigen presentation in a complementary and cooperative fashion
31. The murine cytomegalovirus immune evasion protein m4/gp34 forms biochemically distinct complexes with class I MHC at the cell surface and in a pre-Golgi compartment
32. Temporal regulation of murine cytomegalovirus transcription and mapping of viral RNA synthesized at immediate early times after infection
33. Sequence and structural organization of murine cytomegalovirus immediate-early gene 1
34. Characterization of the major immediate-early polypeptides encoded by murine cytomegalovirus
35. A mouse cytomegalovirus glycoprotein, gp34, forms a complex with folded class I MHC molecules in the ER which is not retained but is transported to the cell surface
36. Antigen processing by the proteasome
37. The immunoevasive function encoded by the mouse cytomegalovirus gene m152 protects the virus against T cell control in vivo
38. Latency versus persistence or intermittent recurrences: Evidence for a latent state of murine cytomegalovirus in the lungs
39. + virus-specific cytotoxic T lymphocytes
40. Structural organization, expression, and functional characterization of the murine cytomegalovirus immediate-early gene 3
41. Structure and expression of murine cytomegalovirus immediate-early gene 2
42. Suppression of murine cytomegalovirus (MCMV) replication with a DNA vaccine encoding MCMV M84 (a homolog of human cytomegalovirus pp65)
43. Murine cytomegalovirus m02 gene family protects against natural killer cell-mediated immune surveillance
44. Murine model of interstitial cytomegalovirus pneumonia in syngeneic bone marrow transplantation: Persistence of protective pulmonary CD8-T-cell infiltrates after clearance of acute infection
45. Analysis of the complete DNA sequence of murine cytomegalovirus
46. The immunogenicity of human and murine cytomegaloviruses
47. The conditions of primary infection define the load of latent viral genome in organs and the risk of recurrent cytomegalovirus disease
48. Cloned long-term cytolytic T-lymphocyte line with specificity for an immediate-early membrane antigen of murine cytomegalovirus
49. Late-phase expression of a murine cytomegalovirus immediate-early antigen recognized by cytolytic T lymphocytes
50. Adoptive immunotherapy of murine cytomegalovirus adrenalitis in the immunocompromised host: CD4-helper-independent antiviral function of CD8-positive memory T lymphocytes derived from latently infected donors
51. The cytolytic T lymphocyte response to the murine cytomegalovirus. I. Distinct maturation stages of cytolytic T lymphocytes constitute the cellular immune response during acute infection of mice with the murine cytomegalovirus
52. The cytolytic T lymphocyte response to the murine cytomegalovirus. II. Detection of virus replication stage-specific antigens by separate populations of in vivo active cytolytic T lymphocyte precursors
53. Significance of herpesvirus immediate early gene expression in cellular immunity to cytomegalovirus infection
54. A pentapeptide as minimal antigenic determinant for MHC class I-restricted T lymphocytes
55. Interstitial murine cytomegalovirus pneumonia after irradiation: Characterization of cells that limit viral replication during established infection of the lungs
56. A cytomegalovirus glycoprotein re-routes MHC class I complexes to lysosomes for degradation
57. Cytotoxic T-lymphocyte response to cytomegalovirus after human allogeneic bone marrow transplantation: Pattern of recovery and correlation with cytomegalovirus infection and disease
58. Class I MHC-restricted cytotoxic T lymphocyte recognition of cells infected with human cytomegalovirus does not require endogenous viral gene expression
59. Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones
60. Cytotoxic T-cell immunity to virus-infected non-haematopoietic cells requires presentation of exogenous antigen
61. Preemptive CDS-T-cell immunotherapy of acute cytomegalovirus infection prevents lethal disease, limits the burden of latent viral genome, and reduces the risk of virus recurrence
62. Peripheral blood mononuclear phagocytes mediate dissemination of murine cytomegalovirus
63. Identification of the mouse cytomegalovirus genomic region affecting major histocompatibility complex class I molecule transport
64. Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor
65. Cytomegaloviruses use multiple mechanisms to elude the host immune response
66. The human cytotoxic T-lymphocyte (CTL) response to cytomegalovirus is dominated by structural protein pp65; frequency, specificity, and T-cell receptor usage of pp65-specific CTL
67. Cut and Trim: Generating MHC class I peptide ligands
68. The luminal part of the murine cytomegalovirus glycoprotein gp40 catalyzes the retention of MHC class I molecules
69. A mouse cytomegalovirus glycoprotein retains MHC class I complexes in the ERGIC/cis-Golgi compartments